Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for allegedly misleading investors regarding its accounts receivable practices during the Class Period from July 18, 2024, to November 12, 2025 [4]. Group 1: Lawsuit Details - The lawsuit claims that Ardent misrepresented its method of determining the collectability of accounts receivable, stating it used detailed historical reviews, while in reality, it relied on a 180-day cliff for reserving accounts [4]. - On November 12, 2025, Ardent disclosed a $43 million reduction in revenue and a $54 million increase in professional liability reserves, leading to a significant drop in share price by approximately 33.8% [5]. Group 2: Investor Actions - Investors have until March 9, 2026, to apply to be appointed as lead plaintiff in the class action, which allows them to oversee litigation and influence key decisions [2]. - The law firm Kirby McInerney LLP is handling the case and encourages affected investors to contact them for more information [7].
ARDT INVESTOR REMINDER: Ardent Health, Inc. Investors Have Until March 9, 2026 To Seek Lead Plaintiff Role With Kirby McInerney LLP